G9785

G9785 — Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist

Q: What is HCPCS code G9785?

G9785 is a HCPCS Level II code for pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist. It sits in the Procedures and Professional Services (Temporary) section.

Q: Does Medicare cover G9785?

The CMS HCPCS file marks G9785 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

Q: How is G9785 paid under the physician fee schedule?

G9785 carries PFS status code M. Measurement code. Used for reporting purposes only; never paid.

HCPCSActiveBETOS Z2

G9785 is a HCPCS Level II code for pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist. It belongs to the Procedures and Professional Services (Temporary) section. Whether Medicare pays it depends on the coverage rule below.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q3-Jul. This states Medicare’s position on the code, not on your particular claim.

Physician fee schedule statusM

Measurement code. Used for reporting purposes only; never paid.

Global period: XXX

Want the dollar amount for your locality? The fee calculator applies your GPCI and the current conversion factor.

The CMS record for G9785

Long descriptor: Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist
Short descriptor: Path report sent
Added: January 1, 2017
BETOS: Z2
Pricing indicator: 00 — Not priced by Part B

Codes adjacent to G9785

HCPCS has no hierarchy — related items simply sit next to each other in the numbering. If G9785 is not quite right, the correct code is very often within a few positions of it.

G9777Patient did not receive at least 2 prophylactic pharmacologic anti-emetic agents of different classes preoperatively and/or intraoperatively
G9778Patients who have a diagnosis of pregnancy at any time during the measurement periodterminated
G9779Patients who are breastfeeding at any time during the performance period
G9780Patients who have a diagnosis of rhabdomyolysis at any time during the performance period
G9781Documentation of medical reason(s) for not currently being a statin therapy user or receiving an order (prescription) for statin therapy (e.g., patients with statin-associated muscle symptoms or an allergy to statin medication therapy, patients who are receiving palliative or hospice care, patients with active liver disease or hepatic disease or insufficiency, patients with end stage renal disease [esrd], or other medical reasons)
G9782History of or active diagnosis of familial hypercholesterolemia
G9783Documentation of patients with diabetes who have a most recent fasting or direct ldl- c laboratory test result < 70 mg/dl and are not taking statin therapyterminated
G9784Pathologists/dermatopathologists providing a second opinion on a biopsy
G9786Pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) was not sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist
G9787Patient alive as of the last day of the measurement year
G9788Most recent bp is less than or equal to 130/80 mm hg
G9789Blood pressure recorded during inpatient stays, emergency room visits, or urgent care visits
G9790Most recent bp is greater than 130/80 mm hg, or blood pressure not documented
G9791Most recent tobacco status is tobacco free
G9792Most recent tobacco status is not tobacco free
G9793Patient is currently on a daily aspirin or other antiplatelet

Questions about G9785

What is HCPCS code G9785?

G9785 is a HCPCS Level II code for pathology report diagnosing cutaneous basal cell carcinoma, squamous cell carcinoma, or melanoma (to include in situ disease) sent from the pathologist/ dermatopathologist to the biopsying clinician for review within 7 days from the time when the tissue specimen was received by the pathologist. It sits in the Procedures and Professional Services (Temporary) section.

Does Medicare cover G9785?

The CMS HCPCS file marks G9785 as "Carrier judgment". Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

How is G9785 paid under the physician fee schedule?

G9785 carries PFS status code M. Measurement code. Used for reporting purposes only; never paid.